We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > NCD

News List

Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management expresspharma
March 26, 2021
In addition to Human Pharma, Boehringer Ingelheim India’s Animal Health business, which focuses on advanced, preventive health solutions for Pets and Poultry, aims to more than double the sales over the coming five years.
Alembic Pharma raises Rs 150 crore via NCDs expressbpd
March 20, 2019
Drug firm Alembic Pharmaceuticals has said it has raised Rs 150 crore through the allotment of non-convertible debentures (NCDs) on private placement basis. These NCDs carry a coupon rate of 8.37 per cent per annum and are proposed to be listed on NSE.
NCD poses major challenge for Asia-Pacific biospectrumasia
October 13, 2017
While NCDs pose a global challenge, it is imperative to highlight that developing countries – whose healthcare systems are already under stress